Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma

NCT07507058 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

RADIATION: Hypofractionated Radiotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences